---
title: References
description: Primary sources, studies, and citations used throughout this guide
---

This page collects the primary research, clinical guidelines, and scholarly sources cited throughout this guide. References are organized by topic with anchor links for easy navigation.

---

<a aria-hidden="true" id="foundational"></a>

## Foundational Studies

<a aria-hidden="true" id="swan"></a>

### SWAN — Study of Women's Health Across the Nation

The largest, longest-running longitudinal study of women through the menopausal transition. Much of what we know about symptom patterns, duration, and racial/ethnic differences comes from SWAN data.

<a aria-hidden="true" id="swan-overview"></a>

**Sowers M, et al.** "SWAN: A Multicenter, Multiethnic, Community-Based Cohort Study of Women and the Menopausal Transition." In: *Menopause: Biology and Pathobiology.* Academic Press, 2000. [SWAN Study Site](https://www.swanstudy.org/)

<a aria-hidden="true" id="swan-vasomotor-duration-2015"></a>

**Avis NE, et al.** ["Duration of Menopausal Vasomotor Symptoms Over the Menopause Transition."](https://doi.org/10.1001/jamainternmed.2014.8063) *JAMA Internal Medicine.* 2015;175(4):531-539.
*Key finding: Median total vasomotor symptom duration was 7.4 years, with significant variation by race/ethnicity.*

<a aria-hidden="true" id="swan-race-duration-2015"></a>

**Freeman EW, et al.** ["Duration of Menopausal Hot Flushes and Associated Risk Factors."](https://doi.org/10.1097/AOG.0b013e31821f9571) *Obstetrics & Gynecology.* 2011;117(5):1095-1104.
*Key finding: Black women experienced vasomotor symptoms for a median of 10 years, compared to 6.5 years for white women.*

<a aria-hidden="true" id="swan-depression-2006"></a>

**Bromberger JT, et al.** ["Depressive Symptoms During the Menopausal Transition: The Study of Women's Health Across the Nation (SWAN)."](https://doi.org/10.1016/j.jad.2007.01.034) *Journal of Affective Disorders.* 2007;103(1-3):267-272.
*Key finding: Risk of depression increases 2-4 times during perimenopause.*

<a aria-hidden="true" id="swan-cognition-2009"></a>

**Greendale GA, et al.** ["Effects of the Menopause Transition and Hormone Use on Cognitive Performance in Midlife Women."](https://doi.org/10.1212/WNL.0b013e3181a71193) *Neurology.* 2009;72(21):1850-1857.
*Key finding: Cognitive difficulties during perimenopause are measurable and generally improve postmenopause.*

<a aria-hidden="true" id="swan-sleep-2008"></a>

**Kravitz HM, et al.** ["Sleep Disturbance During the Menopausal Transition in a Multi-Ethnic Community Sample of Women."](https://doi.org/10.1093/sleep/31.7.979) *Sleep.* 2008;31(7):979-990.

<a aria-hidden="true" id="whi"></a>

### Women's Health Initiative (WHI)

The study that shaped—and complicated—our understanding of hormone therapy.

<a aria-hidden="true" id="whi-initial-2002"></a>

**Writing Group for the WHI Investigators.** ["Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women."](https://doi.org/10.1001/jama.288.3.321) *JAMA.* 2002;288(3):321-333.
*The original WHI findings that led to widespread abandonment of HT.*

<a aria-hidden="true" id="whi-reanalysis-2007"></a>

**Rossouw JE, et al.** ["Postmenopausal Hormone Therapy and Risk of Cardiovascular Disease by Age and Years Since Menopause."](https://doi.org/10.1001/jama.297.13.1465) *JAMA.* 2007;297(13):1465-1477.
*Key reanalysis showing timing matters—the basis for the timing hypothesis.*

<a aria-hidden="true" id="whi-estrogen-alone-2004"></a>

**WHI Steering Committee.** ["Effects of Conjugated Equine Estrogen in Postmenopausal Women with Hysterectomy."](https://doi.org/10.1001/jama.291.14.1701) *JAMA.* 2004;291(14):1701-1712.
*Estrogen-alone arm showed different risk profile than combined therapy.*

<a aria-hidden="true" id="whi-followup-2013"></a>

**Manson JE, et al.** ["Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women's Health Initiative Randomized Trials."](https://doi.org/10.1001/jama.2013.278040) *JAMA.* 2013;310(13):1353-1368.
*Long-term follow-up data.*

<a aria-hidden="true" id="keeps-elite"></a>

### KEEPS and ELITE

Studies that helped establish the timing hypothesis for hormone therapy.

<a aria-hidden="true" id="keeps-2012"></a>

**Harman SM, et al.** ["Timing and Duration of Menopausal Hormone Treatment May Affect Cardiovascular Outcomes."](https://doi.org/10.1016/j.amjmed.2010.09.021) *American Journal of Medicine.* 2011;124(3):199-205.

<a aria-hidden="true" id="elite-2016"></a>

**Hodis HN, et al.** ["Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol."](https://doi.org/10.1056/NEJMoa1505241) *New England Journal of Medicine.* 2016;374(13):1221-1231.
*Key finding: Early initiation (within 6 years of menopause) slowed atherosclerosis progression.*

---

<a aria-hidden="true" id="physiology"></a>

## Hormonal Landscape & Physiology

<a aria-hidden="true" id="straw-2012"></a>

**Harlow SD, et al.** ["Executive Summary of the Stages of Reproductive Aging Workshop +10: Addressing the Unfinished Agenda of Staging Reproductive Aging."](https://doi.org/10.1097/gme.0b013e31824d8f40) *Menopause.* 2012;19(4):387-395.
*The STRAW+10 staging system that defines perimenopause.*

<a aria-hidden="true" id="prior-perimenopause-1998"></a>

**Prior JC.** ["Perimenopause: The Complex Endocrinology of the Menopausal Transition."](https://doi.org/10.1210/edrv.19.4.0341) *Endocrine Reviews.* 1998;19(4):397-428.
*Key finding: Estradiol levels during perimenopause can exceed premenopausal levels by 20-30% in many cycles.*

<a aria-hidden="true" id="santoro-perimenopause-2016"></a>

**Santoro N, et al.** ["Perimenopause: From Research to Practice."](https://doi.org/10.1089/jwh.2015.5556) *Journal of Women's Health.* 2016;25(4):332-339.

<a aria-hidden="true" id="gold-timing-2011"></a>

**Gold EB.** ["The Timing of the Age at Which Natural Menopause Occurs."](https://doi.org/10.1016/j.ogc.2011.05.002) *Obstetrics and Gynecology Clinics of North America.* 2011;38(3):425-440.

---

<a aria-hidden="true" id="vasomotor"></a>

## Hot Flashes & Vasomotor Symptoms

<a aria-hidden="true" id="kndy-neurons-2010"></a>

**Rance NE, et al.** ["Modulation of Body Temperature and LH Secretion by Hypothalamic KNDy (Kisspeptin, Neurokinin B and Dynorphin) Neurons: A Novel Hypothesis on the Mechanism of Hot Flushes."](https://doi.org/10.1016/j.yfrne.2013.02.003) *Frontiers in Neuroendocrinology.* 2013;34(3):211-227.
*Discovery of KNDy neurons and their role in thermoregulation.*

<a aria-hidden="true" id="kndy-mechanism-2017"></a>

**Padilla SL, et al.** ["Kisspeptin Neurons in the Arcuate Nucleus of the Hypothalamus Orchestrate Circadian Rhythms and Metabolism."](https://doi.org/10.1016/j.cub.2019.01.022) *Current Biology.* 2019;29(4):592-604.
*Further research on KNDy neuron function.*

<a aria-hidden="true" id="vasomotor-prevalence"></a>

**Freeman EW, Sherif K.** ["Prevalence of Hot Flushes and Night Sweats Around the World: A Systematic Review."](https://doi.org/10.1080/13697130601181486) *Climacteric.* 2007;10(3):197-214.

---

<a aria-hidden="true" id="mood"></a>

## Mood & Mental Health

<a aria-hidden="true" id="depression-40-percent"></a>

**Freeman EW, et al.** ["Hormones and Menopausal Status as Predictors of Depression in Women in Transition to Menopause."](https://doi.org/10.1001/archpsyc.61.1.62) *Archives of General Psychiatry.* 2004;61(1):62-70.
*Key finding: Women with no history of depression were 2-4 times more likely to develop depression during perimenopause.*

<a aria-hidden="true" id="anxiety-perimenopause"></a>

**Bromberger JT, Epperson CN.** ["Depression During and After the Perimenopause: Impact of Hormones, Genetics, and Environmental Determinants of Disease."](https://doi.org/10.1016/j.ogc.2018.07.007) *Obstetrics and Gynecology Clinics of North America.* 2018;45(4):663-678.

<a aria-hidden="true" id="rage-perimenopause"></a>

**Perich T, et al.** ["Menopause and Illness Course in Bipolar Disorder: A Systematic Review."](https://doi.org/10.1111/bdi.13064) *Bipolar Disorders.* 2021;23(1):29-41.

---

<a aria-hidden="true" id="cognition"></a>

## Cognitive Changes

<a aria-hidden="true" id="brain-fog-real"></a>

**Maki PM, Henderson VW.** ["Cognition and the Menopause Transition."](https://doi.org/10.1097/GME.0000000000000681) *Menopause.* 2016;23(7):803-805.

<a aria-hidden="true" id="weber-cognition-2014"></a>

**Weber MT, et al.** ["Cognition and Mood in Perimenopause: A Systematic Review and Meta-Analysis."](https://doi.org/10.1016/j.jsbmb.2013.06.001) *Journal of Steroid Biochemistry and Molecular Biology.* 2014;142:90-98.
*Key finding: Cognitive difficulties during perimenopause are measurable but generally temporary.*

---

<a aria-hidden="true" id="sleep"></a>

## Sleep

<a aria-hidden="true" id="sleep-40-percent"></a>

**Baker FC, et al.** ["Sleep Problems During the Menopausal Transition: Prevalence, Impact, and Management Challenges."](https://doi.org/10.2147/NSS.S125807) *Nature and Science of Sleep.* 2018;10:73-95.
*Key finding: Approximately 40% of perimenopausal women experience significant sleep disruption.*

<a aria-hidden="true" id="sleep-apnea-risk"></a>

**Mirer AG, et al.** ["Menopausal Hormone Therapy and Sleep-Disordered Breathing: Evidence from the Wisconsin Sleep Cohort."](https://doi.org/10.1097/GME.0000000000001020) *Menopause.* 2017;24(8):856-863.

<a aria-hidden="true" id="sleep-apnea-estrogen"></a>

**Young T, et al.** ["Predictors of Sleep-Disordered Breathing in Community-Dwelling Adults: The Sleep Heart Health Study."](https://doi.org/10.1001/archinte.162.8.893) *Archives of Internal Medicine.* 2002;162(8):893-900.

---

<a aria-hidden="true" id="weight"></a>

## Body Composition & Weight

<a aria-hidden="true" id="visceral-fat-shift"></a>

**Lovejoy JC, et al.** ["Increased Visceral Fat and Decreased Energy Expenditure During the Menopausal Transition."](https://doi.org/10.1038/ijo.2008.31) *International Journal of Obesity.* 2008;32(6):949-958.

<a aria-hidden="true" id="fat-redistribution"></a>

**Greendale GA, et al.** ["Changes in Body Composition and Weight During the Menopause Transition."](https://doi.org/10.1172/jci.insight.124865) *JCI Insight.* 2019;4(5):e124865.
*Key finding: Fat redistribution to visceral stores occurs regardless of total weight change.*

<a aria-hidden="true" id="glp1-menopause"></a>

**Lundgren JR, et al.** ["Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined."](https://doi.org/10.1056/NEJMoa2028198) *New England Journal of Medicine.* 2021;384(18):1719-1730.

---

<a aria-hidden="true" id="pelvic"></a>

## Pelvic Floor & Urogenital

<a aria-hidden="true" id="incontinence-prevalence"></a>

**Nygaard I, et al.** ["Prevalence of Symptomatic Pelvic Floor Disorders in US Women."](https://doi.org/10.1001/jama.300.11.1311) *JAMA.* 2008;300(11):1311-1316.
*Key finding: Nearly 1 in 4 women experience pelvic floor disorders; prevalence increases significantly with menopause.*

<a aria-hidden="true" id="prolapse-prevalence"></a>

**Wu JM, et al.** ["Prevalence and Trends of Symptomatic Pelvic Floor Disorders in U.S. Women."](https://doi.org/10.1097/AOG.0000000000000057) *Obstetrics & Gynecology.* 2014;123(1):141-148.

<a aria-hidden="true" id="vaginal-estrogen-safety"></a>

**ACOG Committee Opinion No. 659.** ["The Use of Vaginal Estrogen in Women with a History of Estrogen-Dependent Breast Cancer."](https://doi.org/10.1097/AOG.0000000000001351) *Obstetrics & Gynecology.* 2016;127(3):e93-e96.

---

<a aria-hidden="true" id="bone"></a>

## Bone Health

<a aria-hidden="true" id="bone-loss-perimenopause"></a>

**Finkelstein JS, et al.** ["Bone Mineral Density Changes During the Menopause Transition in a Multiethnic Cohort of Women."](https://doi.org/10.1210/jc.2007-1876) *Journal of Clinical Endocrinology & Metabolism.* 2008;93(3):861-868.
*Key finding: Most rapid bone loss occurs in late perimenopause and early postmenopause.*

---

<a aria-hidden="true" id="cardiovascular"></a>

## Cardiovascular

<a aria-hidden="true" id="cvd-menopause"></a>

**El Khoudary SR, et al.** ["Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association."](https://doi.org/10.1161/CIR.0000000000000912) *Circulation.* 2020;142(25):e506-e532.

---

<a aria-hidden="true" id="nk3"></a>

## NK3 Receptor Antagonists

<a aria-hidden="true" id="fezolinetant-skylight"></a>

**Johnson KA, et al.** ["Efficacy and Safety of Fezolinetant in Moderate to Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT."](https://doi.org/10.1210/clinem/dgad058) *Journal of Clinical Endocrinology & Metabolism.* 2023;108(8):1981-1997.

<a aria-hidden="true" id="elinzanetant-oasis"></a>

**Depypere H, et al.** ["Efficacy and Safety of Elinzanetant, a Selective Neurokinin Receptor Antagonist for Vasomotor Symptoms."](https://doi.org/10.1097/GME.0000000000002265) *Menopause.* 2024;31(1):9-18.

<a aria-hidden="true" id="elinzanetant-approval-2024"></a>

**FDA News Release.** ["FDA Approves Novel Drug to Treat Moderate to Severe Hot Flashes Caused by Menopause."](https://www.fda.gov/news-events/press-announcements) December 2024.

---

<a aria-hidden="true" id="nonhormone"></a>

## Non-Hormonal Treatments

<a aria-hidden="true" id="nams-nonhormone-2023"></a>

**The Menopause Society.** ["2023 Nonhormone Therapy Position Statement."](https://doi.org/10.1097/GME.0000000000002200) *Menopause.* 2023;30(6):573-590.

<a aria-hidden="true" id="ssri-hot-flashes"></a>

**Loprinzi CL, et al.** ["Venlafaxine in Management of Hot Flashes in Survivors of Breast Cancer: A Randomised Controlled Trial."](https://doi.org/10.1016/S0140-6736(00)03403-6) *Lancet.* 2000;356(9247):2059-2063.

<a aria-hidden="true" id="gabapentin-hot-flashes"></a>

**Guttuso T Jr, et al.** ["Gabapentin's Effects on Hot Flashes in Postmenopausal Women: A Randomized Controlled Trial."](https://doi.org/10.1016/S0029-7844(02)02712-6) *Obstetrics & Gynecology.* 2003;101(2):337-345.

---

<a aria-hidden="true" id="ht-guidelines"></a>

## Hormone Therapy Guidelines

<a aria-hidden="true" id="nams-position-2022"></a>

**The Menopause Society.** ["The 2022 Hormone Therapy Position Statement of The North American Menopause Society."](https://doi.org/10.1097/GME.0000000000002028) *Menopause.* 2022;29(7):767-794.

<a aria-hidden="true" id="nice-guidelines-2015"></a>

**National Institute for Health and Care Excellence.** ["Menopause: Diagnosis and Management."](https://www.nice.org.uk/guidance/ng23) NICE Guideline NG23. November 2015, updated 2019.

---

<a aria-hidden="true" id="herbal"></a>

## Herbal & Complementary Approaches

<a aria-hidden="true" id="black-cohosh-review"></a>

**Leach MJ, Moore V.** ["Black Cohosh (Cimicifuga spp.) for Menopausal Symptoms."](https://doi.org/10.1002/14651858.CD007244.pub2) *Cochrane Database of Systematic Reviews.* 2012;(9):CD007244.

<a aria-hidden="true" id="phytoestrogens-review"></a>

**Lethaby A, et al.** ["Phytoestrogens for Menopausal Vasomotor Symptoms."](https://doi.org/10.1002/14651858.CD001395.pub4) *Cochrane Database of Systematic Reviews.* 2013;(12):CD001395.

<a aria-hidden="true" id="cbt-menopause"></a>

**Ayers B, et al.** ["Effectiveness of Group and Self-Help Cognitive Behavior Therapy in Reducing Problematic Menopausal Hot Flushes and Night Sweats (MENOS 2): A Randomized Controlled Trial."](https://doi.org/10.1097/gme.0b013e31823cc5a2) *Menopause.* 2012;19(7):749-759.

---

<a aria-hidden="true" id="disparities"></a>

## Race, Ethnicity & Health Disparities

<a aria-hidden="true" id="swan-race-timing"></a>

**Gold EB, et al.** ["Factors Related to Age at Natural Menopause: Longitudinal Analyses From SWAN."](https://doi.org/10.1093/aje/kwt012) *American Journal of Epidemiology.* 2013;178(1):70-83.
*Key finding: Black and Hispanic women experience menopause approximately 2 years earlier than white women.*

<a aria-hidden="true" id="healthcare-disparities"></a>

**Pinkerton JV, et al.** ["Racial and Ethnic Differences in Access to Menopause Care in the US."](https://doi.org/10.1097/GME.0000000000002234) *Menopause.* 2023;30(9):897-905.

<a aria-hidden="true" id="pain-bias"></a>

**Hoffman KM, et al.** ["Racial Bias in Pain Assessment and Treatment Recommendations, and False Beliefs About Biological Differences Between Blacks and Whites."](https://doi.org/10.1073/pnas.1516047113) *Proceedings of the National Academy of Sciences.* 2016;113(16):4296-4301.

---

<a aria-hidden="true" id="lgbtq"></a>

## LGBTQ+ Health

<a aria-hidden="true" id="lgbtq-research-gap"></a>

**Bryson MK, et al.** ["Menopause and Aging LGBTQ2S+ Canadians: A Scoping Review."](https://doi.org/10.1111/1467-9566.13582) *Sociology of Health & Illness.* 2023;45(4):778-797.

<a aria-hidden="true" id="trans-health-ucsf"></a>

**UCSF Transgender Care.** ["Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People."](https://transcare.ucsf.edu/guidelines) 2016, updated 2022.

---

<a aria-hidden="true" id="surgical"></a>

## Surgical & Premature Menopause

<a aria-hidden="true" id="surgical-menopause-symptoms"></a>

**Rocca WA, et al.** ["Oophorectomy, Menopause, Estrogen, and Cognitive Aging: The Timing Hypothesis."](https://doi.org/10.1159/000271871) *Neurodegenerative Diseases.* 2010;7(1-3):163-166.

<a aria-hidden="true" id="premature-menopause-health"></a>

**Shuster LT, et al.** ["Premature Menopause or Early Menopause: Long-Term Health Consequences."](https://doi.org/10.1016/j.maturitas.2009.08.003) *Maturitas.* 2010;65(2):161-166.

---

<a aria-hidden="true" id="neurodivergence"></a>

## Neurodivergence & Menopause

<a aria-hidden="true" id="adhd-estrogen"></a>

**Quinn PO, Madhoo M.** ["A Review of Attention-Deficit/Hyperactivity Disorder in Women and Girls: Uncovering This Hidden Diagnosis."](https://doi.org/10.4088/PCC.13r01596) *Primary Care Companion for CNS Disorders.* 2014;16(3):PCC.13r01596.

<a aria-hidden="true" id="autism-menopause"></a>

**Moseley RL, et al.** ["Autistic Women's Experiences of the Menopause and Perimenopause."](https://doi.org/10.1177/13623613231195202) *Autism.* 2024;28(1):254-272.

---

*This reference list is maintained alongside content updates. Last reviewed: January 2026.*
